首页|子痫前期患者血清血管内皮生长因子联合肿瘤坏死因子受体相关因子6水平对不良妊娠结局的预测价值

子痫前期患者血清血管内皮生长因子联合肿瘤坏死因子受体相关因子6水平对不良妊娠结局的预测价值

扫码查看
目的 探究子痫前期(PE)患者血清血管内皮生长因子(VEGF)联合肿瘤坏死因子受体相关因子 6(TRAF6)水平对不良妊娠结局的预测价值.方法 回顾性选取 2018 年 1 月至 2022 年 12 月在江苏省苏州市立医院进行诊治分娩的PE患者 125例纳入研究组,选取同期进行分娩的健康产妇 130 名纳入对照组,比较两组VEGF和TRAF6水平.记录PE患者妊娠结局发生情况;分析影响PE患者妊娠结局的危险因素;受试者操作特征曲线评估VEGF联合TRAF6 水平对PE患者妊娠结局的预测价值.结果 研究组VEGF水平低于对照组,TRAF6 水平高于对照组(P<0.05).PE患者不良妊娠结局的发生率为 32.80%(41/125).不良妊娠结局组VEGF水平低于良好妊娠结局组,TRAF6水平高于良好妊娠结局组(P<0.05).不良妊娠结局组初产妇占比、收缩压、舒张压高于良好妊娠结局组(P<0.05).VEGF(OR=0.146)、TRAF6(OR=4.772)是PE患者不良妊娠结局的影响因素(P<0.05).VEGF、TRAF6及二者联合预测PE患者妊娠结局的曲线下面积分别为0.757、0.760、0.906.结论 VEGF是PE患者妊娠结局的保护因素,TRAF6是危险因素;VEGF与TRAF6联合对患者妊娠结局预测价值较高.
Predictive value of the levels of serum vascular endothelial growth factor combined with tumor necrosis factor receptor associated factor 6 in ad-verse pregnancy outcomes in patients with preeclampsia
Objective To explore the predictive value of the levels of serum vascular endothelial growth factor(VEGF)combined with tumor necrosis factor receptor associated factor 6(TRAF6)in adverse pregnancy outcomes in patients with preeclampsia(PE).Methods One hundred and twenty-five patients with PE who were diagnosed and delivered in Suzhou Municipal Hospital,Jiangsu Province from January 2018 to December 2022 were retrospective selected to be included in study group,at the same time,one hundred and thirty healthy parturients who delivered during the same period were selected to be included in control group,the levels of VEGF and TRAF6 were compared between two groups.The occurrence of pregnancy outcomes in patients with PE was recorded;the risk factors affecting the patients'pregnancy outcomes were analyzed;receiver operating characteristics curve was used to evaluate the predictive value of the levels of VEGF combined with TRAF6 in pregnancy outcomes in patients with PE.Results The level of VEGF in study group was decreased than that in control group,and the level of TRAF6 was increased than that in control group(P<0.05).The incidence of adverse pregnancy outcomes in PE patients was 32.80%(41/125).The level of VEGF in adverse pregnancy outcome group was lower than that in good pregnancy outcome group,and the level of TRAF6 was higher than that in good pregnancy outcome group(P<0.05).The proportion of primipara,systolic blood pressure,and diastolic blood pressure in adverse pregnancy outcome group were higher than those in good pregnancy outcome group(P<0.05).VEGF(OR=0.146)and TRAF6(OR=4.772)were the influential factors for adverse pregnancy outcomes in patients with PE(P<0.05).The areas under the curve of VEGF,TRAF6 and their combination predicted pregnancy outcomes in patients with PE were 0.757,0.760,and 0.906,respectively.Conclusion VEGF is a protective factor for pregnancy outcome in patients with PE and TRAF6 is a risk factor.The combination of VEGF and TRAF6 has a high predictive value for pregnancy outcome.

PreeclampsiaPregnancy outcomesVascular endothelial growth factorTumor necrosis factor receptor associated factor 6

顾纯吉、孙燕瑜、翟静晶、岳永飞、陈燕

展开 >

江苏省苏州市立医院 南京医科大学附属苏州医院医学检验科,江苏苏州 215000

子痫前期 妊娠结局 血管内皮生长因子 肿瘤坏死因子受体相关因子6

江苏省妇幼健康科研项目

F202108

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(8)
  • 25